Vanguard Group’s NeuroOne Medical Technologies NMTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $815K | Buy |
1,202,598
+91,908
| +8% | +$62.3K | ﹤0.01% | 3801 |
|
|
2025
Q1 | $944K | Buy |
1,110,690
+191,162
| +21% | +$162K | ﹤0.01% | 3727 |
|
|
2024
Q4 | $760K | Hold |
919,528
| – | – | ﹤0.01% | 3836 |
|
|
2024
Q3 | $910K | Hold |
919,528
| – | – | ﹤0.01% | 3806 |
|
|
2024
Q2 | $736K | Buy |
919,528
+207
| +0% | +$166 | ﹤0.01% | 3892 |
|
|
2024
Q1 | $1.1M | Buy |
919,321
+1,691
| +0.2% | +$2.03K | ﹤0.01% | 3780 |
|
|
2023
Q4 | $1.45M | Buy |
917,630
+478,149
| +109% | +$755K | ﹤0.01% | 3714 |
|
|
2023
Q3 | $391K | Sell |
439,481
-772
| -0.2% | -$687 | ﹤0.01% | 4123 |
|
|
2023
Q2 | $528K | Sell |
440,253
-4,608
| -1% | -$5.53K | ﹤0.01% | 4104 |
|
|
2023
Q1 | $716K | Buy |
444,861
+355,196
| +396% | +$572K | ﹤0.01% | 4012 |
|
|
2022
Q4 | $108K | Buy |
89,665
+6,747
| +8% | +$8.1K | ﹤0.01% | 4382 |
|
|
2022
Q3 | $141K | Sell |
82,918
-156,473
| -65% | -$266K | ﹤0.01% | 4462 |
|
|
2022
Q2 | $197K | Hold |
239,391
| – | – | ﹤0.01% | 4470 |
|
|
2022
Q1 | $264K | Buy |
239,391
+22,159
| +10% | +$24.4K | ﹤0.01% | 4495 |
|
|
2021
Q4 | $421K | Buy |
+217,232
| New | +$421K | ﹤0.01% | 4456 |
|